Diamedica Therapeutics Inc (DMAC)

Stock-Based Compensation

$1.12M

Quarterly · Period ending: · USD

DMAC logo

DMAC Stock-Based Compensation

Latest reported$1.12M
DMAC Quarterly Stock-Based Comp ($0.00 → $1.12M)
High-resolution chart · PNG

DMAC stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Diamedica Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
1,118,000
822,000
1,192,000
0
771,000
867,000
589,000
565,000
443,000
488,000
456,000
425,000
380,000
422,000
411,000
418,000
365,000
308,000
298,000
303,000
446,000
511,000
506,000
508,000
436,000
393,000
401,000
451,000
182,000
130,000
-71,823
110,000
292,000
153,000
146,917
149,708
67,018
45,357
82,460
39,149
61,891
75,332
86,835
-48,208
43,718
43,141
51,002
183,132
3,801
105,366
120,495
201,972
238,363
143,741
220,230
230,561
377,407
203,872
0
271,461
162,282
182,221
239,548
24,367
29,947
623
9,427
44,478
124,081
74,411
0
21,627
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.